Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Coronary Artery Disease: HELP
Phillip J. Barter
Based on 22 articles published since 2008
||||
Expertise Level
The expertise of Phillip J. Barter ranks in the Graphical view (beta)
Uncounted papers?
Aliases Barter, Phillip J   ·   Barter, Philip J   ·   Barter, Philip
Work Locations
Details
Most likely:    University of New South Wales      
2018
  • School of Medical Sciences, University of New South Wales Australia, Wallace Wurth Building East, Randwick, Sydney, NSW 2031, Australia. · Department of Cardiology, Royal Prince Alfred Hospital, Missenden Road, Camperdown, Sydney, NSW 2050, Australia. · División de Enfermedades Cardiovasculares, Pontificia Universidad Católica de Chile. · School of Medical Sciences, University of New South Wales Australia, Wallace Wurth Building East, Randwick, Sydney, NSW 2031, Australia. Electronic address: · Pubmed 29306454
2017
  • Cleveland Clinic Coordinating Center for Clinical Research (C5R), Cleveland Clinic, Cleveland, OH, United States; Quebec Heart & Lung Institute, Quebec City, Canada; Department of Medicine, University of Adelaide, Adelaide, Australia. · Section of Cardiovascular Research, Baylor College of Medicine, The Methodist DeBakey Heart and Vascular Center, Houston, TX, United States. · Cleveland Clinic Coordinating Center for Clinical Research (C5R), Cleveland Clinic, Cleveland, OH, United States. · Centre for Vascular Research, University of New South Wales, Sydney, Australia. · Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, United States. · INSERM Dyslipidaemia and Atherosclerosis Research Unit, Pitié-Salpetriere University Hospital, Paris, France. · West German Heart Center, Essen, Germany. · Quebec Heart & Lung Institute, Quebec City, Canada. · AstraZeneca, Gaithersburg, MD, United States. · Cleveland Clinic Coordinating Center for Clinical Research (C5R), Cleveland Clinic, Cleveland, OH, United States; Department of Medicine, University of Adelaide, Adelaide, Australia; South Australian Health and Medical Research Institute, Adelaide, Australia. Electronic address: · Pubmed 28641153
2016
  • South Australian Health and Medical Research Institute, PO Box 11060, Adelaide, SA, 5001, Australia. · Department of Cardiovascular Medicine and Cleveland Clinic Coordinating Center for Clinical Research, Cleveland Clinic, Cleveland, OH, USA. · Section of Cardiovascular Research, Baylor College of Medicine and the Methodist DeBakey Heart and Vascular Center, Houston, TX, USA. · University of New South Wales, Sydney, NSW, Australia. · Medstar Research Institute, Hyattsville, MD, USA. · Department of Vascular Medicine, Academic Medical Center, University of Medicine, Amsterdam, The Netherlands. · South Australian Health and Medical Research Institute, PO Box 11060, Adelaide, SA, 5001, Australia. · Department of Cardiology, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands. · Heart and Vascular Center, Semmelweis University, Budapest, Hungary. · Pubmed 26385396
  • School of Medical Sciences, University of New South Wales, High Street, Kensington 2052, Sydney, Australia. · Pubmed 27053456
2015
  • South Australian Health and Medical Research Institute, University of Adelaide, Adelaide, Australia. · Cleveland Clinic Coordinating Center for Clinical Research and Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH. · University of New South Wales, Sydney, Australia. · Medstar Research Institute, Hyattsville, MD. · University of Edinburgh, Edinburgh, Scotland. · Harvard Medical School, Boston, MA. · Duke Clinical Research Institute, Durham, NC. · Pitie-Salpetriere University Hospital, Paris, France. · University of Pennsylvania, Philadelphia, PA. · Columbia University, New York City, NY. · Eli Lilly and Company, Indianapolis, IN. · Pubmed 26678626
2014
  • Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio; C5Research, Cleveland Clinic, Cleveland, Ohio. · Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio. · C5Research, Cleveland Clinic, Cleveland, Ohio. · Section of Cardiovascular Research, Baylor College of Medicine, and the Methodist DeBakey Heart and Vascular Center, Houston, Texas. · Centre for Vascular Research, University of New South Wales, Sydney, Australia. · INSERM Dyslipidaemia and Atherosclerosis Research Unit, Pitié-Salpetriere University Hospital, Paris, France. · West German Heart Center, Essen, Germany. · Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts. · AstraZeneca, Wilmington, Delaware. · South Australian Health and Medical Research Institute, University of Adelaide, Adelaide, Australia. · C5Research, Cleveland Clinic, Cleveland, Ohio; South Australian Health and Medical Research Institute, University of Adelaide, Adelaide, Australia. Electronic address: · Pubmed 25240453
  • From the Department of Cardiovascular Medicine (R.P., S.E.N.) C5Research (R.P., S.E.N., M.S., S.J.N.), Cleveland Clinic, OH · Section of Cardiovascular Research, Baylor College of Medicine, and the Methodist DeBakey Heart and Vascular Center, Houston, TX (C.M.B.) · Centre for Vascular Research, University of New South Wales, Sydney, New South Wales, Australia (P.J.B.) · INSERM Dyslipidaemia and Atherosclerosis Research Unit, Pitié-Salpetriere University Hospital, Paris, France (M.J.C.) · West German Heart Center, Essen, Germany (R.E.) · Cardiovascular Division, Brigham and Women's Hospital, Boston, MA (P.L.) · AstraZeneca, Wilmington, DE (J.S.R.) · and South Australian Health and Medical Research Institute, University of Adelaide, Adelaide, South Australia, Australia (K.U., Y.K., S.J.N.). · Pubmed 25212234
  • Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH. · Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH C5Research, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH. · C5Research, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH. · Section of Cardiovascular Research, Baylor College of Medicine, and the Methodist DeBakey Heart and Vascular Center, Houston, TX. · Centre for Vascular Research, University of New South Wales, Sydney, Australia. · INSERM Dyslipidaemia and Atherosclerosis Research Unit, Pitié-Salpètrière University Hospital, Paris, France. · West German Heart Center, Essen, Germany. · Cardiovascular Division, Brigham and Women's Hospital, Boston, MA. · AstraZeneca, Wilmington, DE. · South Australian Health and Medical Research Institute, University of Adelaide, Adelaide, Australia. · South Australian Health and Medical Research Institute, University of Adelaide, Adelaide, Australia · Pubmed 25190674
  • Centre for Vascular Research, University of New South Wales, Sydney, NSW, Australia; Faculty of Medicine, University of Sydney, Sydney, NSW, Australia. Electronic address: · Department of Biostatistics, University of Washington, Seattle, WA, United States. · Centre for Vascular Research, University of New South Wales, Sydney, NSW, Australia; Faculty of Medicine, University of Sydney, Sydney, NSW, Australia. · Department of Medicine, University of Hong Kong, Hong Kong, China. · Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Johns Hopkins University School of Medicine, Baltimore, MD, United States; Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States. · Division of General Internal Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States. · Department of Family and Preventive Medicine, University of California San Diego, La Jolla, CA, United States. · Departments of Medicine and Pathology, University of Vermont, Burlington, VT, United States. · Department of Family and Preventive Medicine, University of California San Diego, La Jolla, CA, United States. Electronic address: · Pubmed 25108074
  • Centre for Vascular Research, University of New South Wales, Sydney, New South Wales, Australia; Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia. · Division of Cardiology, San Francisco General Hospital and the University of California at San Francisco, San Francisco, California. Electronic address: · Pfizer, Inc., New York, New York. · Pubmed 24666618
2013
  • Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH (R.P., S.E.N., K.U., Y.K., S.J.N.) · Cardiovascular Division, Brigham and Women's Hospital, Boston, MA (P.L.) · C5Research, Cleveland Clinic, Cleveland, OH (M.S.) · Section of Cardiovascular Research, Baylor College of Medicine, and the Methodist DeBakey Heart and Vascular Center, Houston, TX (C.M.B.) · Centre for Vascular Research, University of New South Wales, Sydney, Australia (P.J.B.) · INSERM Dyslipidaemia and Atherosclerosis Research Unit, Hôpital de la Pitié, Paris, France (M.J.C.) · West German Heart Center, Essen, Germany (R.E.) · AstraZeneca, Wilmington, DE (J.S.R.) · and South Australian Health and Medical Research Institute, University of Adelaide, Adelaide, Australia (S.J.N.). · Pubmed 24043299
Probable:    University of Sydney      
2014
  • Centre for Vascular Research, University of New South Wales, Sydney, NSW, Australia; Faculty of Medicine, University of Sydney, Sydney, NSW, Australia. Electronic address: · Department of Biostatistics, University of Washington, Seattle, WA, United States. · Centre for Vascular Research, University of New South Wales, Sydney, NSW, Australia; Faculty of Medicine, University of Sydney, Sydney, NSW, Australia. · Department of Medicine, University of Hong Kong, Hong Kong, China. · Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Johns Hopkins University School of Medicine, Baltimore, MD, United States; Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States. · Division of General Internal Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States. · Department of Family and Preventive Medicine, University of California San Diego, La Jolla, CA, United States. · Departments of Medicine and Pathology, University of Vermont, Burlington, VT, United States. · Department of Family and Preventive Medicine, University of California San Diego, La Jolla, CA, United States. Electronic address: · Pubmed 25108074
  • Centre for Vascular Research, University of New South Wales, Sydney, New South Wales, Australia; Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia. · Division of Cardiology, San Francisco General Hospital and the University of California at San Francisco, San Francisco, California. Electronic address: · Pfizer, Inc., New York, New York. · Pubmed 24666618
Probable:    Miscellaneous institutions in Sydney      
2011
  • The Heart Research Institute, 7 Eliza Street, Newtown, Sydney, NSW 2050, Australia. · Pubmed 22152280
2009
  • The Heart Research Institute, 7 Eliza Street, Newtown, Sydney, New South Wales, Australia 2042. · Pubmed 19895939
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 22 total) written by Phillip J. Barter about Coronary Artery Disease:

  • Transcoronary gradients of HDL-associated MicroRNAs in unstable coronary artery disease. 2018
  • Lipoprotein(a) and coronary atheroma progression rates during long-term high-intensity statin therapy: Insights from SATURN. 2017
  • Effect of the BET Protein Inhibitor, RVX-208, on Progression of Coronary Atherosclerosis: Results of the Phase 2b, Randomized, Double-Blind, Multicenter, ASSURE Trial. 2016
  • Coronary artery disease: Scavenger receptor class B1--a target to reduce CHD risk? 2016
  • Assessment of the clinical effects of cholesteryl ester transfer protein inhibition with evacetrapib in patients at high-risk for vascular outcomes: Rationale and design of the ACCELERATE trial. 2015
  • Sex-related differences of coronary atherosclerosis regression following maximally intensive statin therapy: insights from SATURN. 2014
  • Antiatherosclerotic effects of long-term maximally intensive statin therapy after acute coronary syndrome: insights from Study of Coronary Atheroma by Intravascular Ultrasound: Effect of Rosuvastatin Versus Atorvastatin. 2014
  • High-intensity statin therapy alters the natural history of diabetic coronary atherosclerosis: insights from SATURN. 2014
  • The relationship between insulin resistance and vascular calcification in coronary arteries, and the thoracic and abdominal aorta: the Multi-Ethnic Study of Atherosclerosis. 2014
  • Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial. 2014
Show List of Full Article Records
Google Searches

Learn more about Phillip J. Barter using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of New South Wales
University of Sydney
Miscellaneous institutions in Sydney
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of New South Wales
2018
  • School of Medical Sciences, University of New South Wales Australia, Wallace Wurth Building East, Randwick, Sydney, NSW 2031, Australia. · Department of Cardiology, Royal Prince Alfred Hospital, Missenden Road, Camperdown, Sydney, NSW 2050, Australia. · División de Enfermedades Cardiovasculares, Pontificia Universidad Católica de Chile. · School of Medical Sciences, University of New South Wales Australia, Wallace Wurth Building East, Randwick, Sydney, NSW 2031, Australia. Electronic address: · Pubmed 29306454
2017
  • Cleveland Clinic Coordinating Center for Clinical Research (C5R), Cleveland Clinic, Cleveland, OH, United States; Quebec Heart & Lung Institute, Quebec City, Canada; Department of Medicine, University of Adelaide, Adelaide, Australia. · Section of Cardiovascular Research, Baylor College of Medicine, The Methodist DeBakey Heart and Vascular Center, Houston, TX, United States. · Cleveland Clinic Coordinating Center for Clinical Research (C5R), Cleveland Clinic, Cleveland, OH, United States. · Centre for Vascular Research, University of New South Wales, Sydney, Australia. · Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, United States. · INSERM Dyslipidaemia and Atherosclerosis Research Unit, Pitié-Salpetriere University Hospital, Paris, France. · West German Heart Center, Essen, Germany. · Quebec Heart & Lung Institute, Quebec City, Canada. · AstraZeneca, Gaithersburg, MD, United States. · Cleveland Clinic Coordinating Center for Clinical Research (C5R), Cleveland Clinic, Cleveland, OH, United States; Department of Medicine, University of Adelaide, Adelaide, Australia; South Australian Health and Medical Research Institute, Adelaide, Australia. Electronic address: · Pubmed 28641153
2016
  • South Australian Health and Medical Research Institute, PO Box 11060, Adelaide, SA, 5001, Australia. · Department of Cardiovascular Medicine and Cleveland Clinic Coordinating Center for Clinical Research, Cleveland Clinic, Cleveland, OH, USA. · Section of Cardiovascular Research, Baylor College of Medicine and the Methodist DeBakey Heart and Vascular Center, Houston, TX, USA. · University of New South Wales, Sydney, NSW, Australia. · Medstar Research Institute, Hyattsville, MD, USA. · Department of Vascular Medicine, Academic Medical Center, University of Medicine, Amsterdam, The Netherlands. · South Australian Health and Medical Research Institute, PO Box 11060, Adelaide, SA, 5001, Australia. · Department of Cardiology, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands. · Heart and Vascular Center, Semmelweis University, Budapest, Hungary. · Pubmed 26385396
  • School of Medical Sciences, University of New South Wales, High Street, Kensington 2052, Sydney, Australia. · Pubmed 27053456
2015
  • South Australian Health and Medical Research Institute, University of Adelaide, Adelaide, Australia. · Cleveland Clinic Coordinating Center for Clinical Research and Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH. · University of New South Wales, Sydney, Australia. · Medstar Research Institute, Hyattsville, MD. · University of Edinburgh, Edinburgh, Scotland. · Harvard Medical School, Boston, MA. · Duke Clinical Research Institute, Durham, NC. · Pitie-Salpetriere University Hospital, Paris, France. · University of Pennsylvania, Philadelphia, PA. · Columbia University, New York City, NY. · Eli Lilly and Company, Indianapolis, IN. · Pubmed 26678626
2014
  • Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio; C5Research, Cleveland Clinic, Cleveland, Ohio. · Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio. · C5Research, Cleveland Clinic, Cleveland, Ohio. · Section of Cardiovascular Research, Baylor College of Medicine, and the Methodist DeBakey Heart and Vascular Center, Houston, Texas. · Centre for Vascular Research, University of New South Wales, Sydney, Australia. · INSERM Dyslipidaemia and Atherosclerosis Research Unit, Pitié-Salpetriere University Hospital, Paris, France. · West German Heart Center, Essen, Germany. · Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts. · AstraZeneca, Wilmington, Delaware. · South Australian Health and Medical Research Institute, University of Adelaide, Adelaide, Australia. · C5Research, Cleveland Clinic, Cleveland, Ohio; South Australian Health and Medical Research Institute, University of Adelaide, Adelaide, Australia. Electronic address: · Pubmed 25240453
  • From the Department of Cardiovascular Medicine (R.P., S.E.N.) C5Research (R.P., S.E.N., M.S., S.J.N.), Cleveland Clinic, OH · Section of Cardiovascular Research, Baylor College of Medicine, and the Methodist DeBakey Heart and Vascular Center, Houston, TX (C.M.B.) · Centre for Vascular Research, University of New South Wales, Sydney, New South Wales, Australia (P.J.B.) · INSERM Dyslipidaemia and Atherosclerosis Research Unit, Pitié-Salpetriere University Hospital, Paris, France (M.J.C.) · West German Heart Center, Essen, Germany (R.E.) · Cardiovascular Division, Brigham and Women's Hospital, Boston, MA (P.L.) · AstraZeneca, Wilmington, DE (J.S.R.) · and South Australian Health and Medical Research Institute, University of Adelaide, Adelaide, South Australia, Australia (K.U., Y.K., S.J.N.). · Pubmed 25212234
  • Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH. · Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH C5Research, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH. · C5Research, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH. · Section of Cardiovascular Research, Baylor College of Medicine, and the Methodist DeBakey Heart and Vascular Center, Houston, TX. · Centre for Vascular Research, University of New South Wales, Sydney, Australia. · INSERM Dyslipidaemia and Atherosclerosis Research Unit, Pitié-Salpètrière University Hospital, Paris, France. · West German Heart Center, Essen, Germany. · Cardiovascular Division, Brigham and Women's Hospital, Boston, MA. · AstraZeneca, Wilmington, DE. · South Australian Health and Medical Research Institute, University of Adelaide, Adelaide, Australia. · South Australian Health and Medical Research Institute, University of Adelaide, Adelaide, Australia · Pubmed 25190674
  • Centre for Vascular Research, University of New South Wales, Sydney, NSW, Australia; Faculty of Medicine, University of Sydney, Sydney, NSW, Australia. Electronic address: · Department of Biostatistics, University of Washington, Seattle, WA, United States. · Centre for Vascular Research, University of New South Wales, Sydney, NSW, Australia; Faculty of Medicine, University of Sydney, Sydney, NSW, Australia. · Department of Medicine, University of Hong Kong, Hong Kong, China. · Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Johns Hopkins University School of Medicine, Baltimore, MD, United States; Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States. · Division of General Internal Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States. · Department of Family and Preventive Medicine, University of California San Diego, La Jolla, CA, United States. · Departments of Medicine and Pathology, University of Vermont, Burlington, VT, United States. · Department of Family and Preventive Medicine, University of California San Diego, La Jolla, CA, United States. Electronic address: · Pubmed 25108074
  • Centre for Vascular Research, University of New South Wales, Sydney, New South Wales, Australia; Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia. · Division of Cardiology, San Francisco General Hospital and the University of California at San Francisco, San Francisco, California. Electronic address: · Pfizer, Inc., New York, New York. · Pubmed 24666618
2013
  • Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH (R.P., S.E.N., K.U., Y.K., S.J.N.) · Cardiovascular Division, Brigham and Women's Hospital, Boston, MA (P.L.) · C5Research, Cleveland Clinic, Cleveland, OH (M.S.) · Section of Cardiovascular Research, Baylor College of Medicine, and the Methodist DeBakey Heart and Vascular Center, Houston, TX (C.M.B.) · Centre for Vascular Research, University of New South Wales, Sydney, Australia (P.J.B.) · INSERM Dyslipidaemia and Atherosclerosis Research Unit, Hôpital de la Pitié, Paris, France (M.J.C.) · West German Heart Center, Essen, Germany (R.E.) · AstraZeneca, Wilmington, DE (J.S.R.) · and South Australian Health and Medical Research Institute, University of Adelaide, Adelaide, Australia (S.J.N.). · Pubmed 24043299
University of Sydney
2014
  • Centre for Vascular Research, University of New South Wales, Sydney, NSW, Australia; Faculty of Medicine, University of Sydney, Sydney, NSW, Australia. Electronic address: · Department of Biostatistics, University of Washington, Seattle, WA, United States. · Centre for Vascular Research, University of New South Wales, Sydney, NSW, Australia; Faculty of Medicine, University of Sydney, Sydney, NSW, Australia. · Department of Medicine, University of Hong Kong, Hong Kong, China. · Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Johns Hopkins University School of Medicine, Baltimore, MD, United States; Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States. · Division of General Internal Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States. · Department of Family and Preventive Medicine, University of California San Diego, La Jolla, CA, United States. · Departments of Medicine and Pathology, University of Vermont, Burlington, VT, United States. · Department of Family and Preventive Medicine, University of California San Diego, La Jolla, CA, United States. Electronic address: · Pubmed 25108074
  • Centre for Vascular Research, University of New South Wales, Sydney, New South Wales, Australia; Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia. · Division of Cardiology, San Francisco General Hospital and the University of California at San Francisco, San Francisco, California. Electronic address: · Pfizer, Inc., New York, New York. · Pubmed 24666618
Miscellaneous institutions in Sydney
2011
  • The Heart Research Institute, 7 Eliza Street, Newtown, Sydney, NSW 2050, Australia. · Pubmed 22152280
2009
  • The Heart Research Institute, 7 Eliza Street, Newtown, Sydney, New South Wales, Australia 2042. · Pubmed 19895939
4 Other Locations Show
Yearly article counts 011217312211
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.